Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Pan-Cancer Analysis of IRAK1 Expression and Their Association With Immunotherapy Response

20 May 2022

Abstract excerpt

IRAK1 is an active kinase which plays a critical role in IL-1/TLR signaling pathway involved in inflammation and innate immune response. Recently, increasing evidence supports a potential role of IRAK1 in cancer progression. However, no immunological pan-cancer analysis of IRAK1 is available. We aimed to explore the prognostic value and the immunological functions of IRAK1. A series of datasets including The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35669566
DOI: 10.3389/fmolb.2022.904959

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Pan-Cancer Analysis of IRAK1 Expression and Their Association With Immunotherapy ResponsePMID 35669566Read ↗

Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunctionSemantic proximity Read ↗

Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlasSemantic proximity Read ↗

Pan-Cancer Analysis Reveals RIPK2 Predicts Prognosis and Promotes Immune Therapy Resistance Via Triggering Cytotoxic T Lymphocytes DysfunctionSemantic proximity Read ↗

Death associated protein kinase 1 predicts the prognosis and the immunotherapy response of various cancers.Semantic proximity Read ↗

The Diagnostic and Prognostic Value of LIMK1/2: A Pan-Cancer Analysis.Semantic proximity Read ↗

IL-1 Receptor-Associated Kinase Signaling and Its Role in Inflammation, Cancer Progression, and Therapy ResistanceSemantic proximity Read ↗

Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes.Semantic proximity Read ↗

TLR4 exhibits a Pivotal Role in Immuno-Oncology through Systematic Pan-Cancer AnalysisSemantic proximity Read ↗

PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathwaySemantic proximity Read ↗

U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignanciesSemantic proximity Read ↗

Analysis of PD-1 related immune transcriptional profile in different cancer typesSemantic proximity Read ↗

Pan-cancer analysis on the role of PIK3R1 and PIK3R2 in human tumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.